Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.The British Medical Journal has published a formal apology to Eli Lilly and Company and retracted recent allegations about the company's disclosure of important Prozac information.
Subscribe to our email newsletter
The BMJ report alleged that Lilly failed to provide the FDA with documents relating to the risks associated with the antidepressant.
The apology and retraction references the journal’s own investigation into the Prozac documents and follows a complaint made by Lilly about the allegations. The BMJ wrote: “The BMJ accepts that Eli Lilly acted properly in relation to the disclosure of these documents in these claims.”
“We were disturbed by the initial BMJ article that inaccurately reported about Prozac and made negative inferences regarding our company’s conduct,” stated Sidney Taurel, chairman, president and CEO of Lilly.
“The apology and retraction is an important step in gaining closure on this unfortunate event. We accept the apology and retraction with the understanding that both our organizations are committed to providing doctors and patients with accurate information about medications.”